Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
- 1 December 1997
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 17 (4), 423-430
- https://doi.org/10.1038/ng1297-423
Abstract
Germline mutation of the BRCA2 gene carries a high risk of developing breast cancer. To study the function of this gene, we generated a mutation in Brca2 in mice. Unlike other mutations in the Brca2 gene, which are lethal early in embryogenesis when homozygous, some of our homozygous mutant mice survive to adulthood. These animals have a wide range of defects, including small size, improper differentiation of tissues, absence of germ cells and the development of lethal thymic lymphomas. Fibroblasts cultured from Brca2−/−embryos have a defect in proliferation that may be mediated by over-expression of p53 and p21waf1/Clp1. We show that Brca2 is required for efficient DNA repair, and our results suggest that loss of the p53 checkpoint may be essential for tumour progression triggered by mutations in BRCA2.Keywords
This publication has 46 references indexed in Scilit:
- Breast cancer genes—what are the real risks?Nature Genetics, 1997
- BRCA2 mutations in primary breast and ovarian cancersNature Genetics, 1996
- Mutation analysis in the BRCA2 gene in primary breast cancersNature Genetics, 1996
- Hereditary predisposition to breast cancerCurrent Opinion in Genetics & Development, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Inherited breast and ovarian cancerHuman Molecular Genetics, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990